Key facts
- ARC Medical’s last known valuation is $50.0M (Oct 2025).
- It has raised $20.3M across 3 recorded rounds; the latest was Seed Round ($1.5M) in Oct 2024.
- Notable investors include Lumina Growth Partners, Scenario (Vancouver), The University of British Columbia, WUTIF Capital.
- ARC Medical has filed 15 Form Ds with the SEC since 2021, most recently Aug 2025 ($901K sold to 9 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 3 rounds
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for ARC Medical
Funding rounds
3 roundsAbout ARC Medical
Manufacturer of clinical therapeutic equipment designed to reduce surgical adhesions in humans. The company's equipment consists of a sulfated molecular weight polysaccharide in a physiological salt and improves the quality of life for people who have undergone surgery by developing safe and more effective fluid medical devices, enabling surgeons to reduce the number and strength of post-surgical adhesions.
- Sector
- Healthcare
- HQ
- Richmond, Canada
- Founded
- 2010
- Employees
- 18
- Website
- arcmedinc.com/
- Ownership
- Privately Held (backing)
ARC Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in ARC Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on ARC Medical in its N-PORT filings yet. We sweep new filings monthly.